
DXLG Stock Forecast & Price Target
DXLG Analyst Ratings
Bulls say
Destination XL Group is seeing strong customer metrics from shoppers using their FITMAP technology and expects to further drive customer engagement and sales through promotional initiatives while also implementing an assortment change strategy that focuses on increasing private label sales. However, the company is facing pressure from the weight loss drug GLP-1, which is causing customers to opt for lower-priced products, potentially impacting their margins. Despite this, DXLG is still expected to see growth in merchandise margin and EBITDA in the coming years, positioning the company for long-term success with its unique offering of extended sizes.
Bears say
Destination XL Group is facing challenges with margin pressure and higher markdowns leading to lower than expected earnings. Despite some efforts to improve sales and profits, these initiatives are facing offsetting pressures such as the GLP-1 merger. Additionally, the company's recent merger with FullBeauty is still awaiting closure in 2Q25, adding uncertainty to the company's future performance.
This aggregate rating is based on analysts' research of Destination XL Group and is not a guaranteed prediction by Public.com or investment advice.
DXLG Analyst Forecast & Price Prediction
Start investing in DXLG
Order type
Buy in
Order amount
Est. shares
0 shares